This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Neurology  • Stroke  • Statistics and Research Methods  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their systematic review of aspirin dose for the prevention of cardiovascular disease, Dr Campbell and colleagues¹ conclude that currently available data do not support the routine long-term use of aspirin dosages greater than 75 mg/d to 81 mg/d in the setting of cardiovascular disease prevention. The definition of cardiovascular disease includes stroke, transient ischemic attack, and myocardial infarction. We agree with the authors that aspirin dosage in excess of 300 mg/d is not justified, but suggest the potential for better stroke prevention using aspirin dosage of 160 mg/d compared with 75 mg/d to 81 mg/d.

Of the 11 studies included in the review, the study by Peters et al² compared different aspirin dosages in patients with acute coronary syndrome. However, that article only reported the composite outcome of cardiovascular death, myocardial infarction, and stroke. The relationship between aspirin dosage and stroke incidence may be masked by . . . [Full Text of this Article]

George Kwok Chu Wong, MB ChB, FRCSEd(SN)
georgewong@surgery.cuhk.edu.hk
Division of Neurosurgery
The Chinese University of Hong Kong
Hong Kong

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Aspirin Dose and Cardiovascular Disease Prevention
Andrew Clegg
JAMA. 2007;298(6):625.
EXTRACT | FULL TEXT  

Aspirin Dose and Cardiovascular Disease Prevention—Reply
Charles L. Campbell, Susan Smyth, Steven R. Steinhubl, and Gilles Montalescot
JAMA. 2007;298(6):625-626.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Aspirin Dose for the Prevention of Cardiovascular Disease: A Systematic Review
Charles L. Campbell, Susan Smyth, Gilles Montalescot, and Steven R. Steinhubl
JAMA. 2007;297(18):2018-2024.
ABSTRACT | FULL TEXT